MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s11606-014-2993-8

Медицинская библиотека · Journal of general internal medicine · 2014

Polypharmacy is associated with an increased risk of bleeding in elderly patients with venous thromboembolism.

Leiss Waltraud, Méan Marie, Limacher Andreas, Righini Marc, Jaeger Kurt, Beer Hans-Jürg, Osterwalder Joseph, Frauchiger Beat, Matter Christian M, Kucher Nils, Angelillo-Scherrer Anne, Cornuz Jacques, Banyai Martin, Lämmle Bernhard, Husmann Marc, Egloff Michael, Aschwanden Markus, Rodondi Nicolas, Aujesky Drahomir

СтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Polypharmacy, defined as the concomitant use of multiple medications, is very common in the elderly and may trigger drug-drug interactions and increase the risk of falls in patients receiving vitamin K antagonists.

OBJECTIVE

To examine whether polypharmacy increases the risk of bleeding in elderly patients who receive vitamin K antagonists for acute venous thromboembolism (VTE).

DESIGN

We used a prospective cohort study.

PARTICIPANTS

In a multicenter Swiss cohort, we studied 830 patients aged ≥ 65 years with VTE.

MAIN MEASURES: We defined polypharmacy as the prescription of more than four different drugs. We assessed the association between polypharmacy and the time to a first major and clinically relevant non-major bleeding, accounting for the competing risk of death. We adjusted for known bleeding risk factors (age, gender, pulmonary embolism, active cancer, arterial hypertension, cardiac disease, cerebrovascular disease, chronic liver and renal disease, diabetes mellitus, history of major bleeding, recent surgery, anemia, thrombocytopenia) and periods of vitamin K antagonist treatment as a time-varying covariate.

KEY

RESULTS

Overall, 413 (49.8 %) patients had polypharmacy. The mean follow-up duration was 17.8 months. Patients with polypharmacy had a significantly higher incidence of major (9.0 vs. 4.1 events/100 patient-years; incidence rate ratio [IRR] 2.18, 95 % confidence interval [CI] 1.32-3.68) and clinically relevant non-major bleeding (14.8 vs. 8.0 events/100 patient-years; IRR 1.85, 95 % CI 1.27-2.71) than patients without polypharmacy. After adjustment, polypharmacy was significantly associated with major (sub-hazard ratio [SHR] 1.83, 95 % CI 1.03-3.25) and clinically relevant non-major bleeding (SHR 1.60, 95 % CI 1.06-2.42).

CONCLUSIONS

Polypharmacy is associated with an increased risk of both major and clinically relevant non-major bleeding in elderly patients receiving vitamin K antagonists for VTE.

Для цитирования: Leiss Waltraud, Méan Marie, Limacher Andreas, Righini Marc, Jaeger Kurt, Beer Hans-Jürg, Osterwalder Joseph, Frauchiger Beat, Matter Christian M, Kucher Nils, Angelillo-Scherrer Anne, Cornuz Jacques, Banyai Martin, Lämmle Bernhard, Husmann Marc, Egloff Michael, Aschwanden Markus, Rodondi Nicolas, Aujesky Drahomir. Polypharmacy is associated with an increased risk of bleeding in elderly patients with venous thromboembolism.. Journal of general internal medicine. 2014. DOI: 10.1007/s11606-014-2993-8.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.